1. Home
  2. APM vs HRYU Comparison

APM vs HRYU Comparison

Compare APM & HRYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • HRYU
  • Stock Information
  • Founded
  • APM 2010
  • HRYU 2018
  • Country
  • APM United Kingdom
  • HRYU South Korea
  • Employees
  • APM N/A
  • HRYU N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • HRYU Computer Software: Programming Data Processing
  • Sector
  • APM Health Care
  • HRYU Technology
  • Exchange
  • APM Nasdaq
  • HRYU Nasdaq
  • Market Cap
  • APM 9.8M
  • HRYU 10.5M
  • IPO Year
  • APM 2018
  • HRYU 2023
  • Fundamental
  • Price
  • APM $0.76
  • HRYU $0.23
  • Analyst Decision
  • APM
  • HRYU
  • Analyst Count
  • APM 0
  • HRYU 0
  • Target Price
  • APM N/A
  • HRYU N/A
  • AVG Volume (30 Days)
  • APM 25.7K
  • HRYU 10.6M
  • Earning Date
  • APM 12-20-2024
  • HRYU 11-26-2024
  • Dividend Yield
  • APM N/A
  • HRYU N/A
  • EPS Growth
  • APM N/A
  • HRYU N/A
  • EPS
  • APM N/A
  • HRYU N/A
  • Revenue
  • APM $431,378.00
  • HRYU $528,595.00
  • Revenue This Year
  • APM $157,729.10
  • HRYU N/A
  • Revenue Next Year
  • APM N/A
  • HRYU N/A
  • P/E Ratio
  • APM N/A
  • HRYU N/A
  • Revenue Growth
  • APM N/A
  • HRYU N/A
  • 52 Week Low
  • APM $1.09
  • HRYU $0.17
  • 52 Week High
  • APM $17.49
  • HRYU $1.50
  • Technical
  • Relative Strength Index (RSI)
  • APM 16.33
  • HRYU 47.95
  • Support Level
  • APM $1.21
  • HRYU $0.21
  • Resistance Level
  • APM $1.37
  • HRYU $0.25
  • Average True Range (ATR)
  • APM 0.11
  • HRYU 0.05
  • MACD
  • APM -0.02
  • HRYU -0.00
  • Stochastic Oscillator
  • APM 1.33
  • HRYU 15.11

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

About HRYU Hanryu Holdings Inc.

Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

Share on Social Networks: